‹ ›
MYP_065811
← PREVIOUS NEXT → BACK
Basic Information
QUB-1426
Antimicrobial
Standard
13 amino acids
C71H123N15O15
Standard
Sequence
FLPKLLSALAKIL
Physicochemical Analysis
1426.83 Da
10.00
1.76
1.55
0.1352
1.52
0.60
0.47
25.80
195.38
0.0769
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
476.00
0.53
16.0
17.0
47.0
101.0
2.0
12.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0041977 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Temporin
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
Amidation
APD analysis reveals that this sequence is similar (71.43%) to Temporin-WY2 Leu: 38%; K=A: 15%. Chemical modification: C-terminal amidated
Bio-Activity Profile
Antimicrobial
Pseudomonas aeruginosa ATCC 9027 or PAO1
16-64 μM
MIC
PaperDiscovery and engineering of a novel peptide, Temporin-WY2, with enhanced in vitro and in vivo efficacy against multi-drug resistant bacteria
RECORD: Rec_0200470 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Temporin
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
Amidation
APD analysis reveals that this sequence is similar (71.43%) to Temporin-WY2 Leu: 38%; K=A: 15%. Chemical modification: C-terminal amidated
Bio-Activity Profile
Antimicrobial
disrupted biofilms: Enterococcus faecalis
32 μM
MBEC
PaperDiscovery and engineering of a novel peptide, Temporin-WY2, with enhanced in vitro and in vivo efficacy against multi-drug resistant bacteria
RECORD: Rec_0359269 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Temporin
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
Amidation
APD analysis reveals that this sequence is similar (71.43%) to Temporin-WY2 Leu: 38%; K=A: 15%. Chemical modification: C-terminal amidated
Bio-Activity Profile
Antimicrobial
Enterococcus faecalis NCTC 12697
4 μM
MIC
PaperDiscovery and engineering of a novel peptide, Temporin-WY2, with enhanced in vitro and in vivo efficacy against multi-drug resistant bacteria
RECORD: Rec_0365995 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Temporin
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
Amidation
APD analysis reveals that this sequence is similar (71.43%) to Temporin-WY2 Leu: 38%; K=A: 15%. Chemical modification: C-terminal amidated
Bio-Activity Profile
Antimicrobial
Staphylococcus aureus ATCC CRM 6538 or MRSA BAA 1707 or clinical MRSA B038 V1S1 A
2 μM
MIC
PaperDiscovery and engineering of a novel peptide, Temporin-WY2, with enhanced in vitro and in vivo efficacy against multi-drug resistant bacteria
RECORD: Rec_0408876 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Temporin
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
Amidation
APD analysis reveals that this sequence is similar (71.43%) to Temporin-WY2 Leu: 38%; K=A: 15%. Chemical modification: C-terminal amidated
Bio-Activity Profile
Antimicrobial
Escherichia coli NCTC 8739 or clinical BAA 2340
4 μM
MIC
PaperDiscovery and engineering of a novel peptide, Temporin-WY2, with enhanced in vitro and in vivo efficacy against multi-drug resistant bacteria
1 2 NEXT LAST
Showing 5 records on this page · Page 1 of 2